Results 21 to 30 of about 15,928 (255)

Sexual Dysfunctions and Depression

open access: yesYaşam Becerileri Psikoloji Dergisi, 2019
Although it is widely accepted by psychologists and psychiatrists that there is a correlation between depression and sexual dysfunctions, not enough studies have been conducted on this subject, the focus has been on the interaction between social and ...
Ceyda Polat
doaj   +1 more source

A Cross-sectional Study of Antipsychotic Drugs Induced Sexual Dysfunction among Married Males with Remitted Schizophrenia Attending Tertiary Health Care Centre from Central India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Schizophrenia is a chronic debilitating disease having a major impact on the sufferers’ lives. Antipsychotic drugs are the mainstay of the treatment of schizophrenia.
Rameez Abdul Karim Shaik   +3 more
doaj   +1 more source

Male sexual dysfunction

open access: yesSouth African Medical Journal, 2014
Approximately 31% of men suffer from a sexual dysfunction in their lifetime. This review aims to provide the family practitioner with an approach to managing common cases of male sexual dysfunction, such as erectile dysfunction, using consensus guidelines.
Ramlachan, P, Campbell, M M
openaire   +4 more sources

Sexual dysfunctions in a sample of male psychiatric patients compared to medically ill patients

open access: yesMiddle East Current Psychiatry, 2020
Background Many of the psychiatric disorders and other medical conditions may affect the sexual function of the patients. The present study aims to investigate the frequency of sexual dysfunctions in male psychiatric patients compared to other medically ...
Sameh I. Abdelatti   +2 more
doaj   +1 more source

Epidemiology of Male Sexual Dysfunction

open access: yesAmerican Journal of Men's Health, 2007
Male sexual dysfunction includes erectile dysfunction (ED), ejaculation disorders, orgasmic dysfunctions, and disorders of sexual interest/desire. Although current epidemiologic research supports the high prevalence of ED worldwide, incidence data are ...
Konstantinos Hatzimouratidis MD
doaj   +1 more source

DIABETIC SEXUAL DYSFUNCTION

open access: yesEndocrinology and Metabolism Clinics of North America, 1996
Although the overall incidence of erectile dysfunction in the general population between the ages of 40 and 70 years is 52%, men with diabetes mellitus have impotence at an earlier age and with a significantly higher prevalence, ranging as high as 75%.
L S, Hakim, I, Goldstein
openaire   +2 more sources

Female sexual dysfunction

open access: yesSouth African Medical Journal, 2014
Patients want to discuss concerns about their sexual health, but these discussions can be difficult to initiate. Most patients wait for their healthcare provider to enquire about their sexual health. Female sexual problems are highly prevalent, affecting up to 43% of women. Between a third and half of these women describe their problem/s as distressing,
openaire   +4 more sources

Gynecological diseases as predictors of female sexual dysfunction

open access: yesГинекология, 2021
Background. Female sexual dysfunction is extremely common and affects about half of the worlds women. Currently, the question of the relationship between gynecological morbidity in women and the characteristics of sexual activity and sexual functioning ...
Natalia N. Stenyaeva   +2 more
doaj   +1 more source

Polycystic Ovary Syndrome (PCOS) and Sexual Dysfunctions

open access: yesJournal of Psychosexual Health, 2019
Objectives: Polycystic ovary syndrome (PCOS) is a very common endocrine disorder affecting 5% to 10% of women in reproductive age all over the world. Many comorbidities have been associated with PCOS including infertility, obesity, depression, anxiety ...
Amulya Koneru, Priyanka S
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy